title: Optimizing drug development and use in patients with kidney disease.
authors.affiliation: University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics, 808 Salk Hall, 3501 Terrace Street, Pittsburgh, PA 15261, USA. nolin@pitt.edu
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Nolin
authors.forename: Vikram
authors.initials: V
authors.lastname: Arya
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Sitar
authors.forename: Marc
authors.initials: M
authors.lastname: Pfister
mesh_terms: D015195:Drug Design; D054796:Drug Dosage Calculations; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007668:Kidney / Q000378:metabolism* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000503:physiopathology; D010506:Periodicals as Topic; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism*; D010599:Pharmacokinetics; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D004364:Pharmaceutical Preparations